ArticleInternational journal of women's health2010
Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device.
Article in International journal of women's health, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 131 citations in OpenAlex.
- Extended duration of use of long-acting reversible contraceptives: Systematic review.Canadian family physician Medecin de famille canadien · 2025Pooled it
- Progestin intrauterine devices versus copper intrauterine devices for emergency contraception.The Cochrane database of systematic reviews · 2023Pooled it
- Contraceptive discontinuation and switching among couples receiving integrated HIV and family planning services in Lusaka, Zambia.AIDS (London, England) · 2013Trial
- Article
- Intrauterine device migration into the bladder with resultant bladder stone formation: a case report.Frontiers in medicine · 2026Article
- Article
- Intrauterine device migration into the bladder with urolithiasis: A case report.International journal of surgery case reports · 2025Article
- Placement of the T380A Intrauterine Copper Contraceptive Using a Single-Hand Inserter.O&G open · 2025Article
- Network Meta-Analysis of Randomized Controlled Trials Comparing Safety and Efficacy of Pharmacological Treatments in Reducing Pain During Intrauterine Device Insertion.Sultan Qaboos University medical journal · 2025Review
- Copper Intrauterine Device Migration Into Cesarean Scar Niches Without Complications: A Case Report.Case reports in obstetrics and gynecology · 2025Article
- Review
- Non-Hormonal Contraception.Journal of clinical medicine · 2023Review
- A Prospective Multi-centric Study of Acceptance, Insertion and Follow-Up of Postpartum Insertions of IUCD.Journal of obstetrics and gynaecology of India · 2023Article
- Correlates of post-partum intra-uterine copper-T devices (PPIUCD) acceptance and retention: an observational study from North India.Contraception and reproductive medicine · 2023Article
- Article
- Clinical outcomes of intrauterine device insertions by newly trained providers: The ECHO trial experience.Contraception: X · 2023Article
- Bacterial Biofilm Formation on Nano-Copper Added PLA Suited for 3D Printed Face Masks.Microorganisms · 2022Article
- Immediate Postpartum Copper IUD: A Comparative Analysis between Profiles of Women who Accept and who Refuse it.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2022Article
- Attitudes Toward the Copper IUD in Sweden: A Survey Study.Frontiers in global women's health · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The intrauterine device (IUD), primarily in the form of the copper IUD, is used by more than 150 million women around the world, making it the most widely used reversible method of contraception. With a remarkably low failure rate of less than 1 per 100 women in the first year of use, the Copper T-380A is in the top tier of contraceptives in terms of efficacy. Risks of utilization include perforation and an increased risk of infection in the first 20 days following insertion. Overall, the number of adverse events is low, making the Copper T-380A a very safe contraceptive method. The most common reasons for the discontinuation of this method are menstrual bleeding and dysmenorrhea. However, cumulative discontinuation rates of Copper T-380A are lower than that have been reported for other methods, indicating that the Copper T-380A is highly acceptable to women. After 5 years, approximately 50% of all women, who have a Copper T-380A inserted, will continue to use this highly effective contraceptive method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.